XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Discontinued operations
Instaff
Preferred Stock
Common Stock
Treasury Stock Amount
Additional Paid in Capital
Additional Paid in Capital
Discontinued operations
Instaff
Retained Earnings
Accumulated Other Comprehensive (Loss)/Income
Stockholders’ equity, beginning of period at Dec. 29, 2019 $ 68,456,990   $ 0 $ 103,093 $ (27,318) $ 59,617,787   $ 8,763,428 $ 0
Stockholders’ equity (in shares), beginning of period at Dec. 29, 2019       10,309,236          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation 785,723 $ 63,725       785,723 $ 63,725    
Share issuance costs (10,000)         (10,000)      
Issuance of restricted shares (shares)       (19,143)          
Issuance of restricted shares (2,132)     $ 191 (2,132) (191)      
Cash dividends declared (5,155,148)             (5,155,148)  
Net income 1,441,468             1,441,468  
Other comprehensive gain (loss) (122,874)               (122,874)
Stockholders’ equity, end of period at Dec. 27, 2020 65,457,752   0 $ 103,284 (29,450) 60,457,044   5,049,748 (122,874)
Stockholders’ equity (in shares), end of period at Dec. 27, 2020       10,328,379          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation 1,058,096 53,550       1,058,096 $ 53,550    
Share issuance costs (40,058)         (40,058)      
Issuance of restricted shares (shares)       (64,092)          
Issuance of restricted shares $ (8,442)     $ 640 (8,442) (640)      
Issuance of restricted shares, net of shares of treasury stock (shares)       64,092          
Issuance of ESPP shares (in shares) 31,776     31,776          
Issuance of ESPP shares $ 340,451     $ 318   340,133      
Exercise of common stock shares (in shares) 600     963          
Exercise of common stock shares $ 7,291     $ 10   7,281      
Cash dividends declared (4,567,139)             (4,567,139)  
Net income 14,109,478             14,109,478  
Other comprehensive gain (loss) 181,205               181,205
Stockholders’ equity, end of period at Dec. 26, 2021 76,592,184   0 $ 104,252 (37,892) 61,875,406   14,592,087 58,331
Stockholders’ equity (in shares), end of period at Dec. 26, 2021       10,425,210          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation 1,084,638 $ 7,697              
Transaction fees related sale of discontinued operations           35,093      
Issuance of shares, net of offering costs 3,340,090     $ 2,545   3,337,545      
Issuance of restricted shares, net of shares of treasury stock (shares)       32,344          
Issuance of restricted shares, net of shares of treasury stock $ 0     $ 323 0 (323)      
Issuance of ESPP shares (in shares) 59,506                
Issuance of ESPP shares $ 654,249     $ 594   653,655      
Exercise of common stock options and warrants (shares)       1,000          
Exercise of common stock shares 9,722     $ 11 0 9,711      
Cash dividends declared (6,289,682)             (6,289,682)  
Net income 25,360,873             25,360,873  
Other comprehensive gain (loss) (58,331)                
Stockholders’ equity, end of period at Jan. 01, 2023 $ 100,736,533   $ 0 $ 107,725 $ (37,892) $ 67,003,422   $ 33,663,278 $ 0
Stockholders’ equity (in shares), end of period at Jan. 01, 2023       10,772,515